Publication Name	World Journal of Clinical Oncology
Manuscript ID	13301
Country	Canada

Received	2014-08-16 10:28
Peer-Review Started	2014-08-17 22:20
To Make the First Decision	2014-10-28 14:22
Return for Revision	2014-11-03 09:24
Revised	2014-11-08 03:25
Second Decision	2014-11-28 15:02
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-12-10 17:31
Articles in Press	2014-12-10 17:31
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-01-29 09:43
Publish the Manuscript Online	2015-02-04 11:59

ISSN	2218-4333 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Editorial
Article Title	Axillary lymph node management in breast cancer with positive sentinel lymph node biopsy
Manuscript Source	Invited Manuscript
All Author List	Ioannis A Voutsadakis and Silvana Spadafora
Funding Agency and Grant Number
Corresponding Author	Ioannis A Voutsadakis, MD, PhD, Division of Medical Oncology, Department of Internal Medicine, Sault Area Hospital, 750 Great Northern Road, Sault Ste. Marie, Ontario ON P6B 0A8, Canada. ivoutsadakis@yahoo.com
Key Words	Tumor sub-types; Micro-metastatic; Node positive; Breast cancer; Axillary lymph node dissection; Macro-metastatic; Axillary recurrence
Core Tip	Management of the axilla in breast cancer has been modified by the introduction of sentinel lymph node biopsy. Axillary dissection can be avoided in sentinel lymph node negative patients. More recently, it has been proposed that lymph node dissection could be avoided even in patients with sentinel lymph node positive biopsies. The basis of such proposals is discussed here and caution is advised against a universal omission of lymph node dissection in breast cancer patients with positive sentinel lymph node biopsies. Instead, an individualized approach based on axillary tumor burden and biology of the cancer should be considered.
Publish Date	2015-02-04 11:59
Citation	Voutsadakis IA, Spadafora S. Axillary lymph node management in breast cancer with positive sentinel lymph node biopsy. World J Clin Oncol 2015; 6(1): 1-6
URL	http://www.wjgnet.com/2218-4333/full/v6/i1/1.htm
DOI	http://dx.doi.org/10.5306/wjco.v6.i1.1

Full Article (PDF)	WJCO-6-1.pdf
Full Article (Word)	WJCO-6-1.doc
Manuscript File	13301-Review.doc
Answering Reviewers	13301-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	13301-Conflict-of-interest statement.pdf
Copyright License Agreement	13301-Copyright assignment.pdf
Peer-review Report	13301-Peer review(s).pdf
Scientific Misconduct Check	13301-CrossCheck.jpg
Scientific Editor Work List	13301-Scientific editor work list.pdf